Role of the nervous system in cutaneous diseases;Rôle du système nerveux dans les maladies cutanées

Nouvelles Dermatologiques

Volumn 19, Issue 8, 2000, Pages 595-601

  Misery, L ^a  

^a HÔPITAL NORD   (France)

Author keywords

Dermatose; Immunity; Nervous system; Neurotronsmitter; Skin

Indexed keywords

ACETYLCHOLINE; ADRENALIN; CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ; CORTICOTROPIN; ENDORPHIN; ENKEPHALIN; GASTRIN RELEASING PEPTIDE; GLUTAMIC ACID; INTERMEDIN; MELATONIN; NEUROKININ A; NEUROKININ B; NEUROPEPTIDE Y; NITRIC OXIDE; NORADRENALIN; PEPTIDE HISTIDINE ISOLEUCINE; PROLACTIN; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ATOPIC DERMATITIS; CONTACT DERMATITIS; HUMAN; MELANOMA; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NEUROPATHY; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PSORIASIS; RADIATION INJURY; REVIEW; SKIN DISEASE; SKIN INFLAMMATION; VASCULAR DISEASE; VITILIGO;

EID: 0034428244     PISSN: 07525370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Psychiatrie et dermatologie
2. Prurit
3. Skin, immunity and the nervous system
4. Neuromédiateurs en immunobiologie cutanée
5. La cellule de Merkel
6. Le système neuro-immuno-cutané (S.N.I.C.)
7. Langerhans cells in the neuro-immuno-cutaneous system
8. Psoriasis and the nervous system
9. Expression of substance P-receptors in normal and psoriatic skin
10. Substance P is diminished and vasoactive intestinal neuropeptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes
11. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin
12. Psoriatic keratinocytes express high levels of nerve growth factor
13. Immunohistochemical demonstration of cytokeratin 19- postive basal cells in psoriatic plaques
14. Neuropeptides in psoriasis: Possible role of beta-endorphin in the pathomechanism of the disease
15. Is psoriasis a neuroimmunologic disease?
16. Therapeutic perspectives in psoriasis
17. La capsaïcine en dermatologie
18. Growth hormone, somatostatin and psoriasis
19. Speculations around the mechanism behind the action of peptide T in the healing of psoriasis: A minireview
20. Increased number of immunoreactive nerve fibers in atopic dermatitis
21. Neuropeptides and neuronal marker in atopic dermatitis: A quantified immunohisochemical study
22. Neuropeptides in the skin of patients with atopic dermatitis
23. Two-point discrimination of itch in patients with atopic dermatitis and healthy subjects
24. Atopic eczema and histamine-induced sensations
25. Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects
26. Pruritogenic effects of mitogen-stimulated peripheral blood mononuclear cells in atopic eczema
27. Neuropeptides in skin from patients with atopic dermatitis: An immunohistochemical study
28. An immunohistochemical study of neuroactive substances in the skin of atopic dermatitis
29. Skin levels of vasoactive intestinal polypeptide in atopic dermatitis
30. Substance P levels are decreased in lesional skin of atopic dermatitis
31. Twenty-four hour secretion parameter of prolactin in patients with atopic eczema and normal controls
32. Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis
33. Neurogenic inflammation and the skin: Neural modulation of cutaneous inflammatory reactions
34. Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with atopic dermatitis
35. Atopic eczema can be associated with a mutation in the beta-adrenoreceptor gene
36. Psychodermatolgy: An update
37. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream
38. Génétique du vitiligo
39. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo
40. Psychosomatic concepts in dermatology
41. The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions
42. Morphologic observations on the dermal nerves in vitiligo: An ultrastructural study
43. Neuropeptide and neuronal marker studies in vitiligo
44. Vitiligo
45. Melanocyte innervation in human skin
46. Physiological changes in vitiligo
47. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo
48. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo
49. Catecholamines in vitiligo
50. Hypothesis: Possible role for the melatonin receptor in vitiligo: Discussion paper
51. Single patch of hair at a denervated site in a patient with alopecia universalis
52. Microvascular reactivities in alopecia aerata: Possible involvement of nitric oxide. A study with laser-doppler flowmetry
53. Structure and function of cutaneous nerves in alopecia aerata
54. La reattività del cuoio capelluto alle sostanze neuroorminche ed ai polipeptidi biologicamente attivi nell'alopecia aerata
55. Seborrheic dermatitis in neuroleptic-induced parkinsonism
56. Patients with mood depression have a high prevalence of seborrheic dermatitis
57. Role of neuropeptides in urticaria
58. Beta blocker therapy in cholinergic urticaria
59. Adrenergic urticaria and adrenergic pruritus
60. Skin complaints and work at visual display units: An epidemiological study of office employees
61. Skin changes in patients claiming to suffer from "screen dermatitis": A two-case openfield provocation study
62. A screening of skin changes, with special emphasis on neurochemical marker antibody evaluation, in patients claiming to suffer from « screen dermatitis » as compared to normal healthy controls
63. Depletion of cutaneous peptidergic innervation in HIV-associated xerosis
64. Histopathology of peripheral nerves in cutaneous herpesvirus infection
65. Unilateral localized hyperhidrosis with immunohistochemical evidence of "VIPergic" dysregulation
66. Botulinum toxin therapy for palmar hyperhidrosis
67. Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon
68. Erythromelalgia: Response to serotonin reuptake inhibitors
69. Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: A reappraisal
70. Solar pruritus
71. Brachoradial pruritus: A recurrent solar dermopathy
72. Successful treatment of notalgia paresthetica with topical capsaicin: Vehicle-controlled, double-blind, crossover study
73. Aquadynia: Noradrenergic pain induced by bathing and repsonsive to clonidine
74. Localized pain following contacts with liquids
75. Congenital insensitivity to pain with anhidrosis: Absence of substance P receptors in the skin
76. Cellular changes in denervated tissue during wound healing in a rat model
77. Effect of topical application of nerve growth factor on pressure ulcers
78. Possible neural basis for the field effect in local recurrence of melanoma in situ
79. Immunohistochemical localization of muscarinic receptors in primary and metastatic malignant melanomas
80. The neuroimmunocutaneous system under ultraviolet radiations
81. Modulation of cutaneous SP-receptors in atopic dermatitis after UVA irradiation
82. Effect of UVB 311 nm irradiation on normal human skin
83. Immunomodulation by UV light: Role of neuropeptides
84. Nicotine for pyoderma gangrenosum